Evidence map

ArticleFrontiers in pharmacology2024

Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells.

Zengbin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38835670